Krystyna Szymanska

Prof. Dr. Krystyna Szymanska


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2021 in Genes
Verified
Journal Article
Open access
PDF file
SBSnir Boniel
Snir Boniel
KSKrystyna Szymanska
Krystyna Szymanska
RŚRobert Śmigiel
Robert Śmigiel
KSKrzysztof Szczałuba
Krzysztof Szczałuba
Kabuki syndrome (KS) is a rare developmental disorder principally comprised of developmental delay, hypotonia and a clearly defined dysmorphism: elongation of the structures surrounding the eyes, a shortened and depressed nose, thinning of the upper lip and thickening of the lower lip, large and prominent ears, hypertrichosis and scoliosis. Other characteristics include poor physical growth, cardiac, gastrointestinal and renal anomalies as well as variable behavioral issues, including autistic features. De novo or inherited pathogenic/likely pathogenic variants in the KMT2D gene are the most common cause of KS and account for up to 75% of patients. Variants in KDM6A cause up to 5% of cases (X-linked dominant inheritance), while the etiology of about 20% of cases remains unknown. Current KS diagnostic criteria include hypotonia during infancy, developmental delay and/or intellectual disability, typical dysmorphism and confirmed pathogenic/likely pathogenic variant in KMT2D or KDM6A. Care for KS patients includes the control of physical and psychomotor development during childhood, rehabilitation and multi-specialist care. This paper reviews the current clinical knowledge, provides molecular and scientific links and sheds light on the treatment of Kabuki syndrome individuals.

18 December 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MMMagdalena Mierzewska-Schmidt
Magdalena Mierzewska-Schmidt
ABArtur Baranowski
Artur Baranowski
KSKrystyna Szymanska
Krystyna Szymanska
MCMichal Ciaston
Michal Ciaston
Ernest P. KucharErnest P. Kuchar
Ernest P. Kuchar
IPIzabela Pągowska-Klimek
Izabela Pągowska-Klimek
SARS-CoV-2 infection in healthy children is usually benign. However, severe, life-threatening cases have previously been reported, notably in infants. We must be aware that data on the natural history of COVID-19 are still full of gaps, especially as far as the pediatric population is concerned. Therefore, it is important to describe rare manifestations of SARS-CoV-2 acute infection in children. Here we present the case of acute hemorrhagic necrotizing encephalitis (AHNE) in a previously healthy, 2-month-old male infant with SARS-CoV-2 infection. After 2 days of fever with signs of respiratory tract infection, neurological manifestations appeared: irritability, nystagmus, agitation then apathy. As a consequence of apnea, he required emergent intubation and was transferred to our PICU. Brain MRI revealed diffuse areas of oedema associated with numerous symmetrical changes with punctate hemorrhages in basal ganglia, thalami, brainstem, and cerebral gray matter. CSF was clear with pleocytosis 484 cells/µl, elevated lactic acid and protein. Despite broad microbiological testing, only SARS-CoV2 was detected in PCR nasal swab. Therefore, acute hemorrhagic necrotizing encephalitis (AHNE) as a result of COVID-19 was the most probable diagnosis. The outcome was unfavorable - brain death was confirmed, life support was withdrawn.

13 May 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
KSKrystyna Szymanska
Krystyna Szymanska
KSKrzysztof Szczałuba
Krzysztof Szczałuba
Agnieszka ŁugowskaAgnieszka Ługowska
Agnieszka Ługowska
EOEwa Obersztyn
Ewa Obersztyn
MRMieczyslaw Radkowski
Mieczyslaw Radkowski
UDUrszula Demkow
Urszula Demkow
Inherited encephalopathies include a broad spectrum of heterogeneous disorders. To provide a correct diagnosis, an integrated approach including genetic testing is warranted. We report seven patients with difficult to diagnose inborn paediatric encephalopathies. The diagnosis could not be attained only by means of clinical and laboratory investigations and MRI. Additional genetic testing was required. Cytogenetics, PCR based tests, and array-based comparative genome hybridization were performed. In 4 patients with impaired language abilities we found the presence of microduplication in the region 16q23.1 affecting two dose-sensitive genes:WWOX(OMIM 605131) andMAF(OMIM 177075) (1 case), an interstitial deletion of the 17p11.2 region (2 patients further diagnosed as Smith-Magenis syndrome), and deletion encompassing first three exons of Myocyte Enhancer Factor gene2MEF2C(1 case). The two other cases represented progressing dystonia. Characteristic GAG deletion inDYT1consistently with the diagnosis of torsion dystonia was confirmed in 1 case. Last enrolled patient presented with clinical picture consistent with Krabbe disease confirmed by finding of two pathogenic variants ofGALCgene and the absence of mutations inPSAP. The integrated diagnostic approach including genetic testing in selected examples of complicated hereditary diseases of the brain is largely discussed in this paper.

16 October 2014
Verified
Journal Article
Closed access
FRFilip Rybakowski
Filip Rybakowski
ABAnna Bialek
Anna Bialek
ICIzabela Chojnicka
Izabela Chojnicka
PDPiotr Dziechciarz
Piotr Dziechciarz
AHAndrea Horvath
Andrea Horvath
ADAnna Dunajska
Anna Dunajska

12 March 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Łukasz MańskiŁukasz Mański
Łukasz Mański
Aleksandra MoluszysAleksandra Moluszys
Aleksandra Moluszys
AGAnna Katarzyna Góra
Anna Katarzyna Góra
EWEliza Wasilewska
Eliza Wasilewska
ARAgnieszka Rosa
Agnieszka Rosa
JWJolanta Maria Wierzba
Jolanta Maria Wierzba
Background/Objectives: Joubert syndrome is a rare neurodevelopmental disorder characterized by congenital cerebellar and brainstem malformations affecting networks involved in predictive motor control, sensorimotor integration, and autonomic regulation, resulting in a heterogeneous motor phenotype. Functional impairment is typically described using global gross motor scores, which may not adequately reflect axial control, postural organization, musculoskeletal alignment, or respiratory–postural interactions. The objective of this descriptive pilot case series was to provide a multidimensional functional characterization of children with Joubert syndrome by integrating standardized motor assessments with postural, musculoskeletal, and thoracoabdominal measures. Methods: Six children with genetically and radiologically confirmed Joubert syndrome underwent a single standardized assessment session conducted by the same examiner. This cross-sectional, non-controlled study was based on feasibility sampling, and no a priori power calculation was performed. Gross motor function and postural control were evaluated using the Gross Motor Function Measure-88 and the Balance Assessment Rating Scale. Additional measures included joint range of motion, sacral inclination angle, thoracic configuration, thoracic excursion during quiet breathing, and respiratory rate. Analyses were limited to descriptive statistics. Results: Gross motor performance varied widely across participants, whereas postural control scores did not parallel gross motor performance levels within the cohort. Inter-individual variability was observed in joint mobility, pelvic alignment, and thoracoabdominal configuration, including among children with relatively preserved gross motor scores. Thoracic excursion during quiet breathing demonstrated a relatively narrow and low within-cohort range. Conclusions: In this small exploratory case series, functional characteristics observed in this cohort extended beyond global motor scores. Axial control, postural organization, and thoracoabdominal configuration may represent relevant descriptive domains of functional presentation within a multidimensional framework. Larger, longitudinal, and controlled studies are required to determine their clinical and neurodevelopmental significance.

26 March 2026 in Children
Verified
Journal Article
Open access
PDF file
Łukasz MańskiŁukasz Mański
Łukasz Mański
AMAleksandra Moluszys
Aleksandra Moluszys
EWEliza Wasilewska
Eliza Wasilewska
ARAgnieszka Rosa
Agnieszka Rosa
KSKrzysztof Szczałuba
Krzysztof Szczałuba
JWJolanta Maria Wierzba
Jolanta Maria Wierzba
Background: Joubert syndrome (JS) is a rare ciliopathy characterized by cerebellar and brainstem malformations and the molar tooth sign on magnetic resonance imaging. Motor impairment is primarily driven by axial hypotonia, impaired postural control, and disrupted respiratory-postural integration. Longitudinal reports describing structured neurorehabilitation with standardized functional outcomes remain limited. Case presentation: We report a female child with prenatally suspected vermian hypoplasia and postnatally MRI-confirmed Joubert syndrome. Subsequent molecular testing performed at the age of 3 years and 11 months identified heterozygous variants in the B9D2 gene associated with Joubert syndrome. Early development was marked by axial hypotonia, global motor delay, impaired trunk stabilization, sleep-disordered breathing, and early hip migration. At 2.5 years of age, following motor plateau under conventional therapy, a structured 12-month rehabilitation programme was introduced, combining Vojta-based reflex locomotion, respiratory therapy targeting thoraco-diaphragmatic synchronization, daily home-based practice, and supported standing. Results: After 12 months, gross motor function improved substantially, with GMFM-88 increasing from 12% to 52% (+40 percentage points). PEDI scaled scores improved across all domains, with mobility increasing from 8 to 40, self-care from 15 to 45, and social function from 25 to 50. Ataxia severity decreased from 22 to 15 on the modified Brief Ataxia Rating Scale, consistent with improved trunk stability and coordination. Postural and respiratory organization improved, reflected by a reduction in the subcostal angle from 137° to 90°, an increase in sacral slope from 5° to 10°, and increased expiratory pressure from 10 to 25 mmHg. Caregiver-reported assessment combined with structured clinical observation indicated improved functional visual performance, including enhanced visual attention, visuomotor coordination, and environmental visual interaction. Conclusions: Structured neurorehabilitation was associated with substantial functional improvement across motor, postural, and respiratory domains. These findings support the clinical relevance of mechanism-oriented neurorehabilitation and standardized longitudinal outcome assessment in Joubert syndrome.